Company / Operating Income
Apyx Medical Corp Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$6.4M
FY2025
5-year range
-$23.6M / -$6.4M
FY2021-FY2025
Trend
+65.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$24M to -$6M over the past 2 years.
Based on SEC 10-K filings.
-$6M in FY2025.
Improved from -$24M to -$6M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 65.8% year-over-year.
- Peak operating income was recorded in FY2016.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.4M | +65.8% |
| FY2024 | -$18.8M | +20.0% |
| FY2023 | -$23.6M | +0.0% |
| FY2022 | -$23.6M | -17.3% |
| FY2021 | -$20.1M | +3.8% |
| FY2020 | -$20.9M | -50.3% |
| FY2019 | -$13.9M | -21.9% |
| FY2018 | -$11.4M | -63.1% |
| FY2017 | -$7.0M | -19.4% |
| FY2016 | -$5.8M | -59.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026